|
Volumn 43, Issue 17, 2000, Pages 3348-3350
|
3-Deoxyclocinnamox: The first high-affinity, nonpeptide μ-opioid antagonist lacking a phenolic hydroxyl group
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 DEOXYCLOCINNAMOX;
CLOCINNAMOX;
MORPHINAN DERIVATIVE;
MORPHINONE;
MU OPIATE RECEPTOR ANTAGONIST;
PHENOL;
RECEPTOR SUBTYPE;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ANTINOCICEPTION;
ARTICLE;
BINDING AFFINITY;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
MONKEY;
NONHUMAN;
RECEPTOR AFFINITY;
ANIMALS;
BINDING, COMPETITIVE;
BRAIN;
CLONING, MOLECULAR;
GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE);
HAPLORHINI;
HUMANS;
MORPHINE DERIVATIVES;
NARCOTIC ANTAGONISTS;
RADIOLIGAND ASSAY;
RATS;
RECEPTORS, OPIOID, DELTA;
RECEPTORS, OPIOID, KAPPA;
RECEPTORS, OPIOID, MU;
TUMOR CELLS, CULTURED;
|
EID: 0034710723
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm0009641 Document Type: Article |
Times cited : (16)
|
References (14)
|